Talkin’ About a Resolution: Issues in the Push for Greater Transparency of Medicine Prices Brendan ShawJorge Mestre-Ferrandiz Current Opinion 20 January 2020 Pages: 125 - 134
One-Way Sensitivity Analysis for Probabilistic Cost-Effectiveness Analysis: Conditional Expected Incremental Net Benefit Christopher McCabeMike PauldenPeter Hall Practical Application Open access 16 December 2019 Pages: 135 - 141
A Review of Health Economic Studies Comparing Traditional and Massively Parallel Sequencing Diagnostic Pathways for Suspected Genetic Disorders Patrick FahrJames BuchananSarah Wordsworth Review Article 19 November 2019 Pages: 143 - 158
Measurement Properties of Commonly Used Generic Preference-Based Measures in East and South-East Asia: A Systematic Review Xinyu QianRachel Lee-Yin TanNan Luo Systematic Review Open access 25 November 2019 Pages: 159 - 170
Influence of Modeling Choices on Value of Information Analysis: An Empirical Analysis from a Real-World Experiment David D. KimGregory F. GuzauskasJosh J. Carlson Original Research Article 21 October 2019 Pages: 171 - 179
Cost-Effectiveness of Tenofovir Alafenamide for Treatment of Chronic Hepatitis B in Canada Feng TianSherilyn K. D. HouleWilliam W. L. Wong Original Research Article 06 November 2019 Pages: 181 - 192
How Uncertain is the Survival Extrapolation? A Study of the Impact of Different Parametric Survival Models on Extrapolated Uncertainty About Hazard Functions, Lifetime Mean Survival and Cost Effectiveness Ben KearnsJohn StevensAlan Brennan Original Research Article Open access 25 November 2019 Pages: 193 - 204
Development and Validation of the TRansparent Uncertainty ASsessmenT (TRUST) Tool for Assessing Uncertainties in Health Economic Decision Models Sabine E. GrimmXavier PouwelsManuela A. Joore Original Research Article Open access 11 November 2019 Pages: 205 - 216
Transferability of Economic Evaluations of Treatments for Advanced Melanoma Claire GorryLaura McCullaghMichael Barry Original Research Article Open access 25 November 2019 Pages: 217 - 231
Value in Hepatitis C Virus Treatment: A Patient-Centered Cost-Effectiveness Analysis T. Joseph Mattingly IIJulia F. SlejkoC. Daniel Mullins Original Research Article Open access 02 December 2019 Pages: 233 - 242